 Home > Biochemistry News > Biotechnology News > Keytruda combination therapy for first-line treatment of cervical cancer significantly prolongs patients' overall survival

Keytruda combination therapy for first-line treatment of cervical cancer significantly prolongs patients' overall survival

 Last Update: 2021-08-08
 Source: Internet
 Author: User

Tags

phase separation fuel

beni johnson cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 22, 2021, Merck & Co.

The press release states that Keytruda is the first cancer immunotherapy in this patient group that has achieved positive results as a first-line treatment

Keytruda is a blockbuster anti-PD-1 therapy developed by Merck.

This randomized, double-blind, pivotal phase 3 trial of KEYNOTE-826 enrolled 617 adult patients who have not received systemic chemotherapy and are no longer suitable for radical treatment (such as surgery and/or radiotherapy)

Cervical cancer is one of the most common cancers among women in the world.

Note: The original text has been deleted

Reference materials:

[1] Merck Announces Phase 3 KEYNOTE-826 Trial Met Dual Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Patients With Persistent, Recurrent or Metastatic Cervical Cancer.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.